Related Experiment Videos

The hypertensive neonate

R D Adelman1

  • 1Section of Pediatric Nephrology, University of California, Davis School of Medicine.

Clinics in Perinatology
|September 1, 1988
PubMed

Insights

Neonatal hypertension, often linked to kidney or lung issues, can be treated with medication. While blood pressure may normalize, underlying kidney problems can remain.

Area of Science:

  • Pediatric Nephrology
  • Neonatal Medicine
  • Cardiovascular Research

Background:

  • Neonatal hypertension is frequently secondary to renal vascular or parenchymal disease, or chronic lung disease.
  • Understanding the underlying causes of hypertension in newborns is critical for appropriate management.

Purpose of the Study:

  • To review the common etiologies of neonatal hypertension.
  • To discuss the role and outcomes of antihypertensive medication in neonates.
  • To highlight the potential for persistent renal abnormalities despite effective blood pressure control.

Main Methods:

  • Literature review of studies on neonatal hypertension.
  • Analysis of treatment strategies and their efficacy.
  • Examination of long-term renal outcomes in treated neonates.

Main Results:

  • Antihypertensive medications are effective in lowering blood pressure in neonates.
  • Medication discontinuation is often possible over time.
  • Persistent structural or functional renal abnormalities can occur even after successful blood pressure management.

Conclusions:

  • While antihypertensive therapy can effectively manage neonatal hypertension, it does not always resolve underlying renal pathology.
  • Close monitoring for persistent renal sequelae is essential in neonates treated for hypertension.
  • Further research into the long-term renal impact of neonatal hypertension and its treatment is warranted.

Related Concept Videos